Home » Topics » Regulatory » Patents

Patents
RSS

Gilead Sciences discloses novel agents for AIDS

Nov. 23, 2012

Emory University and Wake Forest University synthesize new NET ligands

Nov. 23, 2012

Canadian group patents new androgen receptor ligands

Nov. 23, 2012

Joyant Pharmaceuticals presents novel agents for cancer

Nov. 23, 2012

Novel nicotinic acetylcholine receptor ligands synthesized at CNRS and INSERM

Nov. 23, 2012

Orion discloses new androgen receptor antagonists

Nov. 23, 2012

Novel agents for tuberculosis patented by GlaxoSmithKline

Nov. 22, 2012

New monoclonal antibodies for cancer presented by U.S. researchers

Nov. 22, 2012

Researchers at Pfizer present new acetyl-CoA carboxylase inhibitors

Nov. 22, 2012

Adamed divulges novel fusion proteins for cancer

Nov. 22, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...